CSF1 and neoplasm: Several therapies, such as granulocyte‐macrophage colony‐stimulating factor (GM‐CSF) and anti‐CSF‐1 antibody, have been used to reprogram the recruited monocytes to differentiate into anti‐tumoral M1 macrophages instead of tumor‐supportive M2 macrophages.10, 14, 15